L-glutamine absorption is enhanced after ingestion of L-alanylglutamine compared with the free amino acid or wheat protein

被引:25
作者
Harris, Roger C. [3 ]
Hoffman, Jay R. [1 ]
Allsopp, Adrian [2 ]
Routledge, Naomi B. H. [3 ]
机构
[1] Univ Cent Florida, Orlando, FL 32816 USA
[2] Inst Naval Med, Gosport PO12 2DL, Hants, England
[3] Junipa Ltd, Newmarket, Suffolk, England
关键词
L-glutamine; L-alanylglutamine; Wheat protein; Absorption; Supplements; Males; ALANYL-L-GLUTAMINE; WATER-ABSORPTION; DEGRADATION KINETICS; PARENTERAL-NUTRITION; DIPEPTIDE ABSORPTION; EXHAUSTIVE EXERCISE; ORAL REHYDRATION; AQUEOUS-SOLUTION; IMMUNE-RESPONSE; HUMAN INTESTINE;
D O I
10.1016/j.nutres.2012.02.003
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Differences in plasma L-glutamine (L-Gln) concentrations from ingestion of different formulations of L-Gln were examined in 8 men (26.8 +/- 4.2 years old, 181.1 +/- 10.9 cm, 85.8 +/- 15.4 kg). Subjects reported to the laboratory on 4 separate occasions and randomly consumed 1 of 4drinks containing 60 mg/kg of L-Gln; 89 mg/kg of Sustamine (L-alanylglutamine [AlaGln]; Kyowa Hakko Europe GmbH, Dusseldorf, Germany), which contained an equivalent L-Gln dose as consumed in L-Gln); 200 mg/kg of an enzymatically hydrolyzed wheat protein (HWP) with an L-Gln content of 31 mg/kg; or a control that consisted only of water. It was hypothesized that the AlaGln trial would increase plasma glutamine concentrations greater than the other experimental trials. Ingestion of L-Gln, AlaGln, and HWP resulted in significant increases in the plasma L-Gln concentration, peaking at 0.5, 0.5, and 0.75 hours, respectively. The corresponding mean peak increases were 179 +/- 61, 284 +/- 84, and 134 +/- 36 mu mol/L, respectively. Concentrations returned to baseline in all subjects by 2 hours after L-Gln and HWP and by 4 hours after AlaGln. Mean areas under the plasma concentration curve, calculated between 0 and 4 hours, were 127 +/- 61, 284 +/- 154, and 151 +/- 63 mu mol(.)h(.)L(-1) for L-Gln, AlaGln, and HWP, respectively. When allowance was made for the lower L-Gln dose administered as HWP, the peak plasma concentration and area under the plasma concentration curve were approximately the same as for AlaGln. The results suggest a greater transfer from the gut to plasma of L-Gln when supplied as AlaGln and possibly also as HWP compared with when the same dose was provided as the free amino acid. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:272 / 277
页数:6
相关论文
共 43 条
[1]   MAXIMUM ACTIVITIES OF SOME ENZYMES OF GLYCOLYSIS, THE TRICARBOXYLIC-ACID CYCLE AND KETONE-BODY AND GLUTAMINE UTILIZATION PATHWAYS IN LYMPHOCYTES OF THE RAT [J].
ARDAWI, MSM ;
NEWSHOLME, EA .
BIOCHEMICAL JOURNAL, 1982, 208 (03) :743-748
[2]  
ARDAWI MSM, 1985, ESSAYS BIOCHEM, V21, P1
[3]   GLUTAMINE-METABOLISM IN LYMPHOCYTES OF THE RAT [J].
ARDAWI, MSM ;
NEWSHOLME, EA .
BIOCHEMICAL JOURNAL, 1983, 212 (03) :835-842
[4]   Degradation kinetics of L-alanyl-L-glutamine and its derivatives in aqueous solution [J].
Arii, K ;
Kai, T ;
Kokuba, Y .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 7 (02) :107-112
[5]   Degradation kinetics of L-glutamine in aqueous solution [J].
Arii, K ;
Kobayashi, H ;
Kai, T ;
Kokuba, Y .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 9 (01) :75-78
[6]  
Castell L. M., 1995, Proceedings of the Nutrition Society, V54, p118A
[7]   Glutamine and the effects of exhaustive exercise upon the immune response [J].
Castell, LM ;
Newsholme, EA .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1998, 76 (05) :524-532
[8]   The effects of oral glutamine supplementation on athletes after prolonged, exhaustive exercise [J].
Castell, LM ;
Newsholme, EA .
NUTRITION, 1997, 13 (7-8) :738-742
[9]   ABSORPTION AND MALABSORPTION OF GLYCINE AND GLYCINE PEPTIDES IN MAN [J].
CRAFT, IL ;
GEDDES, D ;
HYDE, CW ;
WISE, IJ ;
MATTHEWS, DM .
GUT, 1968, 9 (04) :425-+
[10]   RATES OF ABSORPTION BY RAT INTESTINE OF PANCREATIC HYDROLYSATES OF PROTEINS AND THEIR CORRESPONDING AMINO ACID MIXTURES [J].
CRAMPTON, RF ;
GANGOLLI, SD ;
SIMSON, P ;
MATTHEWS, DM .
CLINICAL SCIENCE, 1971, 41 (05) :409-&